#aai? ,,congress #b;d ,session ,h4 ,r4 #hbje ,,an ,,act ,to am5d ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act to reau?orize ! provisions ( su* ,act ?r\gh fiscal ye> #bjca1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,reau?orization ,act ( #bjbf4 #b4 ,reau?orization ( ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7a7 ,9 g5]al ,section #g ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7,public ,law #aag-gi7 is am5d$ by /rik+ #bjbf & ins]t+ #bjca4 7b7 ,grants = ,,als rese>* ,section #b7;f7 ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7#ba ,u4,s4,c4 #cfj;ee note7 is am5d$ by /rik+ #bjbf & ins]t+ #bjca4 #c4 ,improvem5ts to program = grants = rese>* on !rapies = ,,als 7a7 ,r5ewal ( grants = rese>* on !rapies = ,,als review ,section #b7;b7 ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7#ba ,u4,s4,c4 #cfj;ee note7 is am5d$ by add+ at ! end ! foll[+3 7#d7 ,r5ewal ( grants = rese>* on !rapies = ,,als review ,9 review+ applications = r5ewals ( a grant aw>d$ "u ?is section ) respect to an inve/igational drug1 ! ,secret>y %all reque/ f ! manufactur] or sponsor1 & assess1 ! enrollm5t1 safety1 & any available efficacy data relat+ to ! inve/igational drug 9 ! prev5tion1 diagnosis1 mitigation1 treatm5t1 or cure ( amyotrophic lat]al scl]osis4 4 7b7 ,report+ safety data ,section #b7;c7 ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7#ba ,u4,s4,c4 #cfj;ee note7 is am5d$-- 7#a7 9 p>agraph 7#b77;,b71 by /rik+ & at ! end2 7#b7 9 p>agraph 7#c71 by /rik+ ! p]iod at ! end & ins]t+ 2 &2 & 7#c7 by add+ at ! end ! foll[+3 7#d7 ! entity seek+ su* grant w promptly report any new & s]i\s adv]se ev5ts & safety in=mation t is consid]$ to be unexpect$ ) respect to ! phase #c trial to ! grant-mak+ in/itution1 9 addition to comply+ ) ! safety report+ requirem5ts "u section #cab4cb ( title #ba1 ,code ( ,f$]al ,regulations 7or any successor regulations74 4 7c7 ,cl>ify+ p>ticipat+ cl9ical trial def9ition ,section #b7;e7 ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7#ba ,u4,s4,c4 #cfj;ee note7 is am5d$ by add+ at ! end ! foll[+3 7#d7 ,! t]m phase #c1 ) respect to a cl9ical trial1 includes a phase #b_/c comb9$ trial t beg9s enrollm5t )9 a timeframe1 det]m9$ by ! ,secret>y ?r\gh ! t]ms & conditions ( ! grant aw>d$ "u ?is section4 4 #d4 ,,fda r>e neurodeg5]ative disease action plan ,section #d ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,act 7#ba ,u4,s4,c4 #cfj;aa note7 is am5d$-- 7#a7 9 ! section head+1 by /rik+ ,,als & o!r r>e neurodeg5]ative disease action plan & ins]t+ ,,fda r>e neurodeg5]ative disease action plan2 & 7#b7 by add+ at ! end ! foll[+3 7c7 ,,fda r>e neurodeg5]ative disease action plan 7#a7 ,9 g5]al ,n lat] ?an #ah mon?s aft] ! date ( enactm5t ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,reau?orization ,act ( #bjbf1 ! ,commission] ( ,food & ,drugs %all publi% on ! website ( ! ,food & ,drug ,adm9i/ration an action plan t includes a description ( ! actions t ! ,food & ,drug ,adm9i/ration int5ds to take dur+ ! #e-ye> p]iod foll[+ publication ( ! action plan ) respect to ! program enhancem5ts1 policy developm5t1 regulatory sci5ce initiatives1 & o!r appropriate initiatives describ$ 9 subsection 7a74 7#b7 ,report ,n lat] ?an #e ye>s aft] ! date ( enactm5t ( ! ,accel]at+ ,access to ,critical ,!rapies = ,,als ,reau?orization ,act ( #bjbf1 ! ,commission] ( ,food & ,drugs %all publi% on ! website ( ! ,food & ,drug ,adm9i/ration a report t describes ! actions tak5 by ! ,food & ,drug ,adm9i/ration "u ! action plan publi%$ "u p>agraph 7#a7 & ! ext5t to :i* su* action plan meets ! requirem5ts specifi$ 9 p>agraph 7#a74 4 ,pass$ ! ,h\se ( ,repres5tatives ,july #bb1 #bjbf4;,cl]k4